Nisa Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
JAM
RHJA
RWM
IA
NFG
Nisa Investment Advisors's AUPH Position: Q2 2026 in Review
Nisa Investment Advisors increased its Aurinia Pharmaceuticals (AUPH) stake by 21% in Q2 2026, buying an estimated $5.89K and bringing the position to 2,100 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.
Nisa Investment Advisors first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $51K in Q2 2023. 124 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Nisa Investment Advisors held 2,100 shares of Aurinia Pharmaceuticals worth $35.6K as of Q2 2026.
- Nisa Investment Advisors bought 369 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $5.89K.
- Aurinia Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1988 holding.
- Nisa Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- Nisa Investment Advisors's Aurinia Pharmaceuticals position peaked at $51K in Q2 2023.
- 124 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.